GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fresh Tracks Therapeutics Inc (FRA:VCC) » Definitions » E10

Fresh Tracks Therapeutics (FRA:VCC) E10 : €0.00 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Fresh Tracks Therapeutics E10?

Note: As E10 is a main component used to calculate Shiller PE Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation sectione below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fresh Tracks Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 19.70% per year. During the past 5 years, the average E10 Growth Rate was 20.30% per year. During the past 10 years, the average E10 Growth Rate was 20.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Fresh Tracks Therapeutics was 26.00% per year. The lowest was -22.80% per year. And the median was 7.25% per year.

As of today (2024-06-05), Fresh Tracks Therapeutics's current stock price is €0.73. Fresh Tracks Therapeutics's E10 for the quarter that ended in Dec. 2023 was €0.00. Fresh Tracks Therapeutics's Shiller PE Ratio of today is .


Fresh Tracks Therapeutics E10 Historical Data

The historical data trend for Fresh Tracks Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresh Tracks Therapeutics E10 Chart

Fresh Tracks Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -581.16 -377.52 -392.06 -333.57 -

Fresh Tracks Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -333.57 -324.99 -259.57 -235.22 -

Competitive Comparison of Fresh Tracks Therapeutics's E10

For the Biotechnology subindustry, Fresh Tracks Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresh Tracks Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fresh Tracks Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fresh Tracks Therapeutics's Shiller PE Ratio falls into.



Fresh Tracks Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fresh Tracks Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/129.4194*129.4194
=0.000

Current CPI (Dec. 2023) = 129.4194.

Fresh Tracks Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201403 -91.098 99.695 -118.260
201406 -115.920 100.560 -149.188
201409 -122.220 100.428 -157.503
201412 -127.732 99.070 -166.862
201503 -116.424 99.621 -151.248
201506 -84.200 100.684 -108.231
201509 -8.420 100.392 -10.855
201512 -75.184 99.792 -97.505
201603 -73.546 100.470 -94.737
201606 -39.249 101.688 -49.953
201609 -67.360 101.861 -85.584
201612 -74.655 101.863 -94.851
201703 -73.631 102.862 -92.641
201706 -84.105 103.349 -105.321
201709 -71.357 104.136 -88.682
201712 -55.897 104.011 -69.552
201803 -74.085 105.290 -91.064
201806 -59.321 106.317 -72.211
201809 -18.897 106.507 -22.962
201812 -47.071 105.998 -57.472
201903 98.766 107.251 119.181
201906 -30.665 108.070 -36.723
201909 -67.419 108.329 -80.544
201912 -55.890 108.420 -66.715
202003 -18.326 108.902 -21.779
202006 -17.183 108.767 -20.446
202009 -5.731 109.815 -6.754
202012 -5.548 109.897 -6.534
202103 -5.670 111.754 -6.566
202106 -6.051 114.631 -6.832
202109 -6.078 115.734 -6.797
202112 -2.390 117.630 -2.630
202203 -3.223 121.301 -3.439
202206 -0.407 125.017 -0.421
202209 -2.091 125.227 -2.161
202212 -1.416 125.222 -1.463
202303 -1.065 127.348 -1.082
202306 -0.360 128.729 -0.362
202309 0.300 129.860 0.299
202312 0.000 129.419 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Fresh Tracks Therapeutics  (FRA:VCC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Fresh Tracks Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Fresh Tracks Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresh Tracks Therapeutics (FRA:VCC) Business Description

Traded in Other Exchanges
Address
5777 Central Avenue, Suite 102, Boulder, CO, USA, 80301
Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.

Fresh Tracks Therapeutics (FRA:VCC) Headlines

No Headlines